NovaBay Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NovaBay Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.04M, a 31.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.04M -$484K -31.7% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.13M -$508K -31.1% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.21M -$532K -30.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.3M -$535K -29.2% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $1.53M -$411K -21.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.64M -$581K -26.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.74M -$587K -25.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.83M +$1.42M +345% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $1.94M +$1.77M +1039% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.22M +$1.96M +746% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.33M +$1.98M +566% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $411K -$25K -5.73% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $170K -$348K -67.2% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $262K -$541K -67.4% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $350K -$678K -66% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $436K -$816K -65.2% Dec 31, 2020 10-K 2022-03-29
Q3 2020 $518K -$917K -63.9% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $803K -$852K -51.5% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.03M -$842K -45% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.25M Dec 31, 2019 10-K 2021-03-25
Q3 2019 $1.44M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.66M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $1.87M Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.